Hydrogen Therapy Shows Promise for Stroke Recovery and Brain Protection
- Authors
- Ho-Chang Kuo, Kuang-Den Chen, Ping-Chia Li
- Journal
- Chemical Research in Toxicology
- Year
- 2023
- DOI
- 10.1021/acs.chemrestox.3c00259
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Taiwan
- Health Condition
- Ischemic Stroke
- Body System
- Nervous System
TL;DR
Scientists found that a simple gas called molecular hydrogen might help treat strokes by reducing inflammation and damage in the brain, and it seems safe to use in different ways like breathing it in or drinking hydrogen-enriched water. This could become an important new tool to help stroke patients recover better, but doctors need to do more testing to figure out the best way to give it to people.
Key Finding
Molecular hydrogen shows promise as a potential additional treatment for ischemic stroke based on its ability to reduce inflammation and protect cells, though it remains experimental and is not yet an approved medical treatment.
Summary
This review examined research on molecular hydrogen—a simple gas that may help protect brain cells—as a potential treatment for ischemic stroke (a type of stroke caused by a blood clot). Researchers looked at studies testing different ways to deliver hydrogen to the body, including breathing it in, injecting it, or drinking hydrogen-enriched water. The review concluded that early evidence suggests hydrogen may reduce damage from stroke by fighting inflammation and cell death, though more research is needed to determine the best dose and delivery method.
Practical Takeaway
While this review suggests hydrogen may have therapeutic potential for stroke, it is based on early-stage research and does not represent proven clinical treatment. The studies reviewed were mostly preclinical (laboratory and animal studies), and the authors themselves call for further optimization before hydrogen could become a standard stroke therapy. Anyone interested in stroke prevention or treatment should consult their healthcare provider about evidence-based options.
Abstract
Ischemic stroke is a major cause of death and disability worldwide. However, only intravenous thrombolysis using mechanical thrombectomy or tissue plasminogen activator is considered an effective and approved treatment. Molecular hydrogen is an emerging therapeutic agent and has recently become a research focus. Molecular hydrogen is involved in antioxidative, anti-inflammatory, and antiapoptotic functions in normal physical processes and may play an important role in stroke management; it has been evaluated in numerous preclinical and clinical studies in several administration formats, including inhalation of hydrogen gas, intravenous or intraperitoneal injection of hydrogen-enriched solution, or drinking of hydrogen-enriched water. In addition to investigation of the underlying mechanisms, the safety and efficacy of using molecular hydrogen have been carefully evaluated, and favorable outcomes have been achieved. All available evidence indicates that molecular hydrogen may be a promising treatment option for stroke management in the future. This review aimed to provide an overview of the role of molecular hydrogen in the management of stroke and possible further modifications of treatment conditions and procedures in terms of dose, duration, and administration route.